WSA
SZYM

Wall Street Associates’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

Wall Street Associates’s Portfolio SZYM Stock Details SZYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-113,079
Closed -$1.33M – 356
2014
Q2 		$1.33M Sell
113,079
-13,600
-11% -$145K 0.11% 196
2014
Q1 		$1.47M Buy
126,679
+46,746
+58% +$550K 0.12% 192
2013
Q4 		$870K Sell
79,933
-5,060
-6% -$49.8K 0.07% 223
2013
Q3 		$917K Sell
84,993
-914
-1% -$10.4K 0.09% 215
2013
Q2 		$1.01M Buy
+85,907
New +$858K 0.1% 190

Other funds holding SZYM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PC
Passport Capital San Francisco, California $394M AUM 50.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T
Tahithromos New York $71.9M AUM 0.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Wall Street Associates's SZYM Position: Q3 2014 in Review

Wall Street Associates sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q3 2014, closing a stake of 113,079 shares — an estimated $1.33M sold.

Wall Street Associates first reported a position in SZYM in Q2 2013 and held it in 5 quarters. The position peaked at $1.47M in Q1 2014. 120 funds tracked by Wall St. Rank hold SZYM as of Q3 2014.

  • Wall Street Associates reported no remaining SOLAZYME INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • Wall Street Associates sold 113,079 SOLAZYME INC COM STK (DE) shares in Q3 2014, an estimated $1.33M.
  • Wall Street Associates first reported a position in SOLAZYME INC COM STK (DE) in Q2 2013 and held it in 5 quarters.
  • Wall Street Associates's SOLAZYME INC COM STK (DE) position peaked at $1.47M in Q1 2014.
  • 120 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q3 2014.

Based on Wall Street Associates's 13F filing for Q3 2014, filed 13 Nov 2014.